MedTrace Logo

Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice

NCT00128765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2011-11-22

No results posted yet for this study

Summary

In this randomized controlled trial, three contemporary modes for chronic obstructive pulmonary disease (COPD) management in Dutch general practices are compared for costs and effects:

* usual general practitioner (GP) care (at patient's initiative);
* regular practice nurse review; and
* integrated self-management education.

All three interventions are based on existing guidelines, materials, and field experiences.

Conditions

  • Lung Diseases, Obstructive

Interventions

BEHAVIORAL

an integrated self-management education program

disease specific self-management program 'Living Well with COPD', developed in Montreal, Canada

BEHAVIORAL

regular practice nurse review (monitoring controls)

protocol based on existing Guidelines: Dutch College of General Practitioners (NHG) Global Initiative for Chronic Obstructive Lung Disease (GOLD)

BEHAVIORAL

care at initiative of the patient (usual GP care)

care at initiative of the patient (usual GP care)

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • PICASSO: Partners in Care Solutions for COPD

    collaborator OTHER

  • Erasmus Medical Center

    collaborator OTHER

  • McGill University

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Chris van Weel, FRCP · Department of General Practice, Radboud University, Nijmegen, The Netherlands

  • Tjard Schermer, PhD · Department of General Practice, Radboud University, Nijmegen, The Netherlands

  • Erik Bischoff, MD · Department of General Practice, Radboud University, Nijmegen, The Netherlands

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00128765 on ClinicalTrials.gov